Trademark: 79198074
Word
OURLOOP
Status
Registered
Status Code
700
Status Date
Tuesday, August 14, 2018
Serial Number
79198074
Registration Number
5537615
Registration Date
Tuesday, August 14, 2018
Mark Type
4000
Filing Date
Wednesday, July 6, 2016
Published for Opposition
Tuesday, May 29, 2018

Trademark Owner History
Monsenso ApS - Original Registrant
H. Lundbeck A-S - Original Applicant

Classifications
41 Education in the nature classes, seminars, workshops in the field of clinical, medical, pharmaceutical and medical diagnostic research and development; providing of training in the form of courses, seminars, workshops in the field of clinical, medical, pharmaceutical and medical diagnostic research and development; arranging and conducting seminars, conferences, symposiums, workshops and courses in the field of clinical, medical, pharmaceutical and medical diagnostic research and development; educational services in the nature of classes, seminars, and workshops, and training services in the field of research and development, science, clinical tests, diagnostic, medicine, pharmaceuticals, disorders, diseases, treatment and prevention related to assessment of cognitive functions; providing the aforementioned services electronically, on-line, via Internet or other electronic media; arranging and conducting expert in person educational forums in the field of clinical, medical, pharmaceutical and medical diagnostic research and development; on-line training programs in the form of courses, seminars, workshops in the field of research and development, science, clinical tests, diagnostic medicine, pharmaceuticals, and with regard to disorders, diseases, treatment and prevention related to assessment of cognitive functions; providing on-line, non-downloadable publications, namely, books, reports, brochures, booklets, patient information leaflets, magazines, journals, teaching and educational material in the field of research and development, science, clinical tests, diagnostic medicine, pharmaceuticals with regard to disorders, diseases, treatment and prevention related to assessment of cognitive functions
9 Downloadable electronic publications in the nature of books, reports, brochures, booklets, leaflets, patient information leaflets, magazines, journals, teaching and educational material in the field of clinical, medical, pharmaceutical or clinical or medical diagnostic research and development, clinical tests, clinical or medical diagnostic, medicine, pharmaceuticals, medical disorders, medical diseases, clinical or medical treatment and prevention; application software for mobile devices for clinical or medical diagnostic purposes relating to mental or behavioral health; downloadable electronic publications in the nature of brochures, books, magazines related to assessment of cognitive functions; applications software for mobile devices for assessment of cognitive functions; downloadable software for assessment of cognitive functions; software application for measuring psychical and mental health; software used as an installation tool for software applications to retrieve data which is sent automatically
5 Vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of Alzheimer's disease and disorder, stroke, depression, cognitive impairment, mood disorders, psychosis, anxiety, epilepsy, sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, schizophrenia, bipolar disorder and disease, ADHD, cancer, pain, alcoholism and dependency; diagnostic preparations, substances, reagents and agents for medical purposes; pharmaceuticals for treatment of cognitive disorders
44 Medical and healthcare services, namely, providing medical clinics providing assessment of cognitive functions and therapeutic services, namely, the treatment of cognitive disorders and diseases; medical services in the field of psychiatry and psychology and diagnosis and treatment of central nervous system diseases and disorders; medical advice related to medical and pharmaceutical preparations and substances; healthcare and medical services related to central nervous system and brain disorders; providing medical and medicinal information in the field of diagnostics, pharmaceuticals, disorders, diseases, treatment and prevention; providing on-line medical data and analyses designed to provide patients with customized information, including information regarding medical dose, diagnosis, therapeutic issues; remote monitoring of data relating to patients health and diagnostics all offered via an Internet portal or an interactive platform
10 Surgical and medical apparatus and instruments; diagnostic apparatus and instruments for medical purposes for monitoring patient behavior and medication compliance; integrated medical systems containing medical instruments and software for information and information management for use of a Web-based physical and psychological and neurological examination and assessment of patients and clients at a distance and at a clinic; medical instruments for information, guidance and control of medicines
42 Pharmaceutical research and development; scientific and technological services, namely, research in the field of medical disorders, medical diseases and medical treatment; scientific and technological services, namely, research in the field of the central nervous system and related disorders, diseases and pharmaceuticals related thereto; medical research and tests in the field of assessment of cognitive functions for mental or behavioral ill health; clinical research and tests in the field of the assessment of cognitive functions; providing online non-downloadable screening software for assessment of cognitive functions

Trademark Events
Aug 14, 2023
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Dec 21, 2018
Final Decision Transaction Processed By Ib
Dec 4, 2018
Final Disposition Notice Sent To Ib
Dec 4, 2018
Final Disposition Processed
Nov 14, 2018
Final Disposition Notice Created, To Be Sent To Ib
Aug 14, 2018
Registered-Principal Register
Jun 1, 2018
Notification Of Possible Opposition - Processed By Ib
May 29, 2018
Official Gazette Publication Confirmation E-Mailed
May 29, 2018
Published For Opposition
May 25, 2018
Notification Processed By Ib
May 16, 2018
Notification Of Possible Opposition Sent To Ib
May 16, 2018
Notification Of Possible Opposition Created, To Be Sent To Ib
May 9, 2018
Notification Of Possible Opposition Sent To Ib
May 9, 2018
Notification Of Notice Of Publication E-Mailed
May 9, 2018
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Apr 20, 2018
Law Office Publication Review Completed
Apr 13, 2018
Approved For Pub - Principal Register
Apr 10, 2018
Teas/Email Correspondence Entered
Apr 9, 2018
Correspondence Received In Law Office
Apr 9, 2018
Teas Response To Office Action Received
Feb 13, 2018
Notification Of Non-Final Action E-Mailed
Feb 13, 2018
Non-Final Action E-Mailed
Feb 13, 2018
Non-Final Action Written
Feb 12, 2018
Notification Of Non-Final Action E-Mailed
Feb 12, 2018
Non-Final Action E-Mailed
Feb 12, 2018
Non-Final Action Written
Feb 12, 2018
Previous Allowance Count Withdrawn
Feb 6, 2018
Withdrawn From Pub - Og Review Query
Jan 24, 2018
Approved For Pub - Principal Register
Jan 10, 2018
Teas/Email Correspondence Entered
Jan 9, 2018
Correspondence Received In Law Office
Jan 9, 2018
Teas Response To Office Action Received
Aug 24, 2017
Notification Of Non-Final Action E-Mailed
Aug 24, 2017
Non-Final Action E-Mailed
Aug 24, 2017
Non-Final Action Written
Aug 21, 2017
Previous Allowance Count Withdrawn
Aug 8, 2017
Withdrawn From Pub - Og Review Query
Jul 24, 2017
Approved For Pub - Principal Register
Jul 24, 2017
Examiner's Amendment Entered
Jul 24, 2017
Notification Of Examiners Amendment E-Mailed
Jul 24, 2017
Examiners Amendment E-Mailed
Jul 24, 2017
Examiners Amendment -Written
Jul 14, 2017
Teas/Email Correspondence Entered
Jul 14, 2017
Correspondence Received In Law Office
Jul 7, 2017
Assigned To Lie
Jun 5, 2017
Teas Change Of Correspondence Received
Jun 5, 2017
Teas Response To Office Action Received
Apr 8, 2017
Refusal Processed By Ib
Mar 30, 2017
Change Of Owner Received From Ib
Dec 30, 2016
Non-Final Action Mailed - Refusal Sent To Ib
Dec 30, 2016
Refusal Processed By Mpu
Dec 27, 2016
Non-Final Action (Ib Refusal) Prepared For Review
Dec 26, 2016
Non-Final Action Written
Dec 23, 2016
Application Filing Receipt Mailed
Dec 19, 2016
Assigned To Examiner
Dec 19, 2016
New Application Office Supplied Data Entered
Dec 15, 2016
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24